Reviva to participate in the h.c. wainwright 25th annual global investment conference

Cupertino, calif., sept. 07, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), inflammatory and cardiometabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will both present and participate in a conference panel at the h.c. wainwright 25th annual global investment conference, taking place september 11-13, 2023 virtually and in new york city, new york.
RVPH Ratings Summary
RVPH Quant Ranking